Too much for Medicare?, hot, hot housing and America’s ammo shortage
Biogen’s new Alzheimer’s Disease drug is being hailed as a medical breakthrough. But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate. Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April. Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO. And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore.
June 29, 202144m 59s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Biogen’s new Alzheimer’s Disease drug is being hailed as a medical breakthrough.
But could its $56,000 per year price tag be too much for Medicare to handle? We’ll debate.
Plus, home prices just posted their biggest gain in the history of the Case-Shiller Index, up 15% in April.
Can the hot housing market keep rolling? And are investors actually driving up prices? We’ll ask Coldwell Banker’s CEO.
And, record gun sales are leading to an ammunition shortage across America. Can the manufacturers catch up to demand? We’ll explore.
Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.